Cancer Supply Strains and Biotech Capital

Kilder

• STAT: STAT+: Cancer drug shortages keep disrupting patient care
• BioPharma Dive: mRNA cancer vaccines’ biggest barriers to market
• Pharmavoice: Merck builds around Keytruda; prediction markets raise new risks - pharmavoice.com
• Endpoints: Alzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drug
• BioPharma Dive: This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.